# RHUZDAH
> **ANDA207585** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2022-10-11
## Drug
- **FDA Application Number:** ANDA207585
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RHUZDAH
- **Generic name:** NORETHINDRONE AND ETHINYL ESTRADIOL TABLET
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Discontinued
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2022-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207585)
---
*MORVS · CC0 1.0*